M&A Deal Summary

Seven2 Acquires Expereo International

On May 25, 2018, private equity firm Seven2 acquired communications company Expereo International from The Carlyle Group

Acquisition Highlights
  • This is Seven2’s 2nd transaction in the Communications sector.
  • This is Seven2’s 1st transaction in the Netherlands.
Investment Fate
  • Expereo International was sold to a consortium of financial buyers in 2021.

M&A Deal Summary

Date 2018-05-25
Target Expereo International
Sector Communications
Buyer(s) Seven2
Sellers(s) The Carlyle Group
Deal Type Secondary Buyout

Target

Expereo International

Amsterdam, Netherlands
Expereo International is a provider of managed Internet network services, SD-WAN, Security and Cloud Connectivity optimisation solutions for global enterprises. Expereo International was founded in 2004 and is based in Amsterdam, Netherlands.

Search 202,137 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try For Free 7-Day Free Trial

Buyer(S) 1

Buyer

Seven2

Investor Investor Investor Investor Investor


Category Private Equity Firm
Founded 1972
PE ASSETS 4.8B EUR
Size Large
Type Sector Agnostic
DESCRIPTION

Seven2 is a private equity firm focused on investments in listed and unlisted small and midcap companies located in Continental Europe. The Firm targets growing businesses in the tech and telecom, consumer, and healthcare services sectors valued between €10 million and €1 billion. Seven2 generally has a five year investment horizon and considers minority and majority positions. Seven2 was established in 1972 and is headquartered in Paris, France.


DEAL STATS #
Overall 11 of 33
Sector (Communications) 2 of 4
Type (Secondary Buyout) 5 of 14
Country (Netherlands) 1 of 3
Year (2018) 2 of 3
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2018-01-01 Eric Bompard

Neuilly-sur-Seine, France

Eric Bompard is an European retailer of cashmere for women, men and children. Eric Bompard was founded in 1984 and is based in Neuilly-sur-Seine, France.

Buy -
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2018-09-20 AEB

Brescia, Italy

AEB is a provider of biotechnology solutions and process enablers for the food and beverage sector, particularly for the oenology market. AEB offers a wide range of products, allowing users to take advantage of the most innovative wine processing and treatment techniques. The result of advanced scientific and technical research, AEB products make use of unique formulations, answering in a targeted way any problem and need concerning the entire winemaking process. AEB was founded in 1963 and is based in Brescia, Italy.

Buy -

Seller(S) 1

SELLER

The Carlyle Group

Washington, District of Columbia, United States

Investor Investor Investor Investor Investor


Category Private Equity Firm
Founded 1987
PE ASSETS 435.0B USD
Size Mega
Type Sector Agnostic
DESCRIPTION
Carlyle's corporate headquarters on Pennsylvania Ave. in Washington, DC.
Carlyle's corporate headquarters on Pennsylvania Ave. in Washington, DC.

The Carlyle Group is a global investment firm that pursues private equity, credit, and real estate investments worldwide. Carlyle's private equity practice practice pursues buyouts, strategic minority equity investments, equity private placements, consolidations and buildups, and growth capital financings. With offices in 19 countries, Carlyle can easily target opportunities throughout North America, Europe, Asia, Australia, the Middle East/North Africa and Latin America. Broad sectors of interest include aerospace, defense, automotive and transportation, consumer, retail, energy and power, financial services, healthcare, industrial, infrastructure, technology services, business services, telecommunications and media. The Carlyle Group was formed in 1987 and is based in Washington DC.


DEAL STATS #
Overall 353 of 482
Sector (Communications) 18 of 19
Type (Secondary Buyout) 76 of 117
Country (Netherlands) 4 of 6
Year (2018) 10 of 15
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2018-05-21 Millicent Pharma

Dundalk, Ireland

Millicent Pharma is a pharmaceutical company that is focused on improving patient lives and outcomes and seeks to acquire, develop, manufacture, and commercialize pharmaceutical products globally. Millicent Pharma was founded in 2018 and is based in Dundalk, Ireland.

Buy -
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2018-06-29 Codorniu

Sant Sadurní d'Anoia, Spain

Codorniu is a manufacturer of high-end cava (sparkling wine) and wines. Codorniu is based in Sant Sadurní d'Anoia, Spain.

Buy -